Willis Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.2M | Buy |
1,717,937
+4,473
| +0.3% | +$119K | 2.63% | 6 |
|
|
2025
Q4 | $42.7M | Buy |
1,713,464
+9,824
| +0.6% | +$248K | 2.2% | 9 |
|
|
2025
Q3 | $43.4M | Sell |
1,703,640
-15,018
| -0.9% | -$371K | 2.37% | 7 |
|
|
2025
Q2 | $41.7M | Buy |
1,718,658
+196,230
| +13% | +$4.58M | 2.44% | 9 |
|
|
2025
Q1 | $38.6M | Buy |
1,522,428
+103,590
| +7% | +$2.71M | 2.59% | 8 |
|
|
2024
Q4 | $37.6M | Buy |
1,418,838
+121,632
| +9% | +$3.3M | 2.47% | 10 |
|
|
2024
Q3 | $37.5M | Buy |
1,297,206
+6,966
| +0.5% | +$203K | 2.44% | 10 |
|
|
2024
Q2 | $36.1M | Buy |
1,290,240
+70,173
| +6% | +$1.93M | 2.5% | 8 |
|
|
2024
Q1 | $33.9M | Buy |
1,220,067
+43,568
| +4% | +$1.21M | 2.33% | 11 |
|
|
2023
Q4 | $33.9M | Buy |
1,176,499
+106,048
| +10% | +$3.21M | 2.38% | 10 |
|
|
2023
Q3 | $35.5M | Buy |
1,070,451
+47,517
| +5% | +$1.68M | 2.69% | 8 |
|
|
2023
Q2 | $37.5M | Buy |
1,022,934
+55,732
| +6% | +$2.17M | 2.45% | 6 |
|
|
2023
Q1 | $39.5M | Buy |
967,202
+84,963
| +10% | +$3.67M | 2.58% | 6 |
|
|
2022
Q4 | $45.2M | Buy |
882,239
+61,361
| +7% | +$2.94M | 2.89% | 3 |
|
|
2022
Q3 | $35.9M | Sell |
820,878
-71,319
| -8% | -$3.47M | 2.61% | 4 |
|
|
2022
Q2 | $46.8M | Sell |
892,197
-2,511
| -0.3% | -$128K | 2.87% | 3 |
|
|
2022
Q1 | $46.3M | Sell |
894,708
-18,472
| -2% | -$958K | 2.45% | 8 |
|
|
2021
Q4 | $53.9M | Sell |
913,180
-175,792
| -16% | -$8.71M | 2.84% | 5 |
|
|
2021
Q3 | $46.8M | Buy |
1,088,972
+19,855
| +2% | +$880K | 2.68% | 7 |
|
|
2021
Q2 | $41.9M | Buy |
1,069,117
+49,188
| +5% | +$1.91M | 2.47% | 11 |
|
|
2021
Q1 | $37M | Sell |
1,019,929
-16,795
| -2% | -$596K | 2.24% | 14 |
|
|
2020
Q4 | $38.2M | Sell |
1,036,724
-42,787
| -4% | -$1.57M | 2.61% | 7 |
|
|
2020
Q3 | $37.6M | Buy |
1,079,511
+191
| +0% | +$6.7K | 3.37% | 2 |
|
|
2020
Q2 | $33.5M | Sell |
1,079,320
-11,651
| -1% | -$396K | 2.6% | 3 |
|
|
2020
Q1 | $33.8M | Sell |
1,090,971
-1,249
| -0.1% | -$42.6K | 2.8% | 5 |
|
|
2019
Q4 | $40.6M | Buy |
1,092,220
+1,520
| +0.1% | +$54.1K | 2.63% | 3 |
|
|
2019
Q3 | $37.2M | Buy |
1,090,700
+234,012
| +27% | +$8.51M | 2.49% | 4 |
|
|
2019
Q2 | $35.2M | Buy |
856,688
+447,947
| +110% | +$17.8M | 2.38% | 4 |
|
|
2019
Q1 | $12.3M | Sell |
408,741
-357,452
| -47% | -$14.3M | 0.85% | 53 |
|
|
2018
Q4 | $31.7M | Sell |
766,193
-36,295
| -5% | -$1.51M | 2.36% | 3 |
|
|
2018
Q3 | $33.6M | Sell |
802,488
-57,280
| -7% | -$2.21M | 2.31% | 4 |
|
|
2018
Q2 | $29.6M | Buy |
859,768
+1,829
| +0.2% | +$62.5K | 2.18% | 4 |
|
|
2018
Q1 | $28.9M | Sell |
857,939
-77,790
| -8% | -$2.67M | 2.23% | 5 |
|
|
2017
Q4 | $32.2M | Buy |
935,729
+7,727
| +0.8% | +$263K | 2.26% | 5 |
|
|
2017
Q3 | $31.4M | Buy |
928,002
+15,932
| +2% | +$512K | 2.27% | 4 |
|
|
2017
Q2 | $29.1M | Buy |
912,070
+2,561
| +0.3% | +$80.8K | 2.2% | 4 |
|
|
2017
Q1 | $29.5M | Buy |
909,509
+8,093
| +0.9% | +$255K | 2.21% | 4 |
|
|
2016
Q4 | $27.8M | Buy |
901,416
+111,493
| +14% | +$3.4M | 2.07% | 5 |
|
|
2016
Q3 | $25.4M | Buy |
789,923
+34,689
| +5% | +$1.16M | 2.03% | 4 |
|
|
2016
Q2 | $25.2M | Sell |
755,234
-26,051
| -3% | -$831K | 2.15% | 5 |
|
|
2016
Q1 | $22M | Buy |
781,285
+7,456
| +1% | +$213K | 1.93% | 7 |
|
|
2015
Q4 | $23.7M | Buy |
773,829
+78,586
| +11% | +$2.47M | 2.16% | 5 |
|
|
2015
Q3 | $20.7M | Buy |
695,243
+25,274
| +4% | +$810K | 2.03% | 5 |
|
|
2015
Q2 | $21.3M | Sell |
669,969
-88,756
| -12% | -$2.89M | 2.03% | 5 |
|
|
2015
Q1 | $25M | Buy |
758,725
+97,279
| +15% | +$3.09M | 2.32% | 3 |
|
|
2014
Q4 | $19.5M | Buy |
661,446
+964
| +0.1% | +$27.6K | 1.83% | 9 |
|
|
2014
Q3 | $18.5M | Sell |
660,482
-4,227
| -0.6% | -$119K | 1.95% | 6 |
|
|
2014
Q2 | $18.7M | Buy |
664,709
+77,352
| +13% | +$2.2M | 1.83% | 8 |
|
|
2014
Q1 | $17.9M | Sell |
587,357
-31
| -0% | -$924 | 1.81% | 9 |
|
|
2013
Q4 | $17.1K | Buy |
587,388
+17,422
| +3% | +$507K | 0.79% | 13 |
|
|
2013
Q3 | $15.1M | Hold |
569,966
| – | – | 1.73% | 12 |
|
|
2013
Q2 | $15.1M | Buy |
+569,966
| New | +$15.7M | 1.73% | 12 |
|
Other funds holding PFE
VCM
VPM
Willis Investment Counsel's PFE Position: Q1 2026 in Review
Willis Investment Counsel increased its Pfizer (PFE) stake by 0.26% in Q1 2026, buying an estimated $119K and bringing the position to 1,717,937 shares worth $48.2M. The position accounts for 2.63% of the portfolio, ranked #6.
Willis Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $53.9M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Willis Investment Counsel held 1,717,937 shares of Pfizer worth $48.2M as of Q1 2026.
- Willis Investment Counsel bought 4,473 Pfizer shares in Q1 2026, an estimated $119K.
- Pfizer made up 2.63% of Willis Investment Counsel's portfolio in Q1 2026, its #6 holding.
- Willis Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Willis Investment Counsel's Pfizer position peaked at $53.9M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.